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Background: Endogenous inhibitors of nitric oxide synthase including asymmetric dimethylarginine (ADMA) have been implicated in the 
pathogenesis and outcome of atherosclerotic vascular disease. We investigated the associations of ADMA and three additional markers in the 
L-arginine metabolic pathway with the ankle-brachial index (ABI), a measure of atherosclerotic burden
Methods: Participants included 1,247 African-Americans (mean age ± SD, 64.2 ± 9.0 years, 71% women) and 1143 non-Hispanic whites (59.7 ± 
9.7 years, 57% women) belonging to sibships ascertained on the basis of hypertension. Serum levels of L-arginine, ADMA, symmetric dimethylarginine 
(SDMA), and monomethylarginine (L-NMMA) were measured by a validated LC-MS/MS method. Generalized estimating equations (to account for the 
presence of siblings) were used to assess whether serum levels of markers were associated with ABI, after adjustment for conventional risk factors 
(smoking history, hypertension, type II diabetes, body mass index, total and high-density lipoprotein cholesterol), previous myocardial infarction or 
stroke, medication use (statin, aspirin and estrogen) and estimated glomerular filtration rate (eGFR).
Results: After adjusting for age and sex, serum levels of ADMA, SDMA and L-NMMA were lower while L-arginine was higher in African-Americans 
than in non-Hispanic whites (p<0.00005 for each biomarker). After adjustment for age, sex, conventional risk factors, previous myocardial infarction 
or stroke, and eGFR, higher levels of SDMA (p=0.0129) and L-NMMA (p=0.0029) were associated with lower ABI in African-Americans. Higher levels 
of SDMA (OR 1.45, 95% CI 1.15 to 1.84) were associated with peripheral arterial disease (PAD), defined as an ABI<0.9, after adjustment. In non-
Hispanic whites, none of the markers was independently associated with ABI or PAD.
Conclusions: Levels of L-arginine metabolism markers differ by ethnicity. Higher serum levels of SDMA and L-NMMA were associated with lower ABI 
and PAD in African-Americans but not in non-Hispanic whites.
